Trastuzumab in Esophagogastric Cancer: HER2-Testing and Treatment Reality outside Clinical Studies in Germany

Figure 1

Percentage of patients tested for HER2-expression in relation to age compared in the actual cohort documented in 2010 and 2011 to patients documented in 2012 and 2013. In total in 2010 and 2011 589 of 1123 documented patients (52%) and in 2012 and 2013 540 of 640 (79%) documented patients were tested for HER2-expression.